检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease: A Health-Economic Analysis of DAPA-CKD.

Phil McEwan,Oliver Darlington,Ryan Miller,John J V McMurray,David C Wheeler,Hiddo J L Heerspink,Andrew Briggs,Klas Bergenheim,Juan Jose Garcia Sanchez

Kidney International Reports（2022）

引用 11|浏览3
暂无评分
摘要
Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD), NCT03036150.
更多
查看译文
关键词
SGLT2 inhibitor,chronic kidney disease,cost-effectiveness,dapagliflozin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要